Kronos Bio, Inc.
KRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $85 | $64 | $76 | $340 |
| Short-Term Investments | $28 | $109 | $162 | $0 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | -$10 | -$1 |
| Other Curr. Assets | $3 | $6 | $6 | $7 |
| Total Curr. Assets | $115 | $179 | $244 | $348 |
| Property Plant & Equip (Net) | $7 | $30 | $38 | $42 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $2 | $10 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $3 | $0 |
| Total NC Assets | $9 | $35 | $51 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $124 | $213 | $295 | $391 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $5 | $1 |
| Short-Term Debt | $3 | $3 | $5 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $10 | $0 | $9 |
| Other Curr. Liab. | $8 | $11 | $12 | $8 |
| Total Curr. Liab. | $15 | $25 | $21 | $14 |
| LT Debt | $22 | $25 | $29 | $32 |
| Deferred Rev, NC | $0 | $4 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $22 | $30 | $29 | $33 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $25 | $28 | $31 | $34 |
| Total Liabilities | $37 | $54 | $50 | $46 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$595 | -$509 | -$396 | -$263 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $682 | $668 | $641 | $608 |
| Total Equity | $88 | $159 | $244 | $345 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $124 | $213 | $295 | $391 |
| Net Debt | -$60 | -$36 | -$43 | -$304 |